Hera S.p.A.
Hera S.p.A. (HRASF) Financial Performance & Income Statement Overview
Explore the financials of Hera S.p.A. (HRASF), including yearly and quarterly data on income, cash flow, and balance sheets.
Hera S.p.A. (HRASF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Hera S.p.A. HRASF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.32B | $4.87B | $2.65B | $2.25B |
| Cost of Revenue | $2.69B | $3.38B | $1.11B | $2.18B |
| Gross Profit | $1.63B | $1.49B | $1.54B | $68.60M |
| Gross Profit Ratio | $0.38 | $0.31 | $0.58 | $0.03 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $20.20M | $33.70M | $23.10M | $0.00 |
| Operating Expenses | $1.38B | $1.18B | $1.40B | -$70.60M |
| Total Costs & Expenses | $4.07B | $4.56B | $2.51B | $2.11B |
| Interest Income | $41.60M | -$32.60M | $36.30M | $35.50M |
| Interest Expense | $59.10M | $31.30M | $73.30M | $67.40M |
| Depreciation & Amortization | $170.80M | $154.70M | $141.30M | $134.80M |
| EBITDA | $463.90M | $400.90M | $314.80M | $315.40M |
| EBITDA Ratio | $0.11 | $0.08 | $0.12 | $0.14 |
| Operating Income | $247.20M | $307.40M | $137.40M | $139.20M |
| Operating Income Ratio | $0.06 | $0.06 | $0.05 | $0.06 |
| Other Income/Expenses (Net) | -$13.20M | -$4.70M | -$33.50M | -$22.50M |
| Income Before Tax | $234.00M | $302.70M | $103.90M | $116.70M |
| Income Before Tax Ratio | $0.05 | $0.06 | $0.04 | $0.05 |
| Income Tax Expense | $70.20M | $78.90M | $29.10M | $32.70M |
| Net Income | $153.70M | $211.60M | $64.50M | $75.30M |
| Net Income Ratio | $0.04 | $0.04 | $0.02 | $0.03 |
| EPS | $0.11 | $0.15 | $0.04 | $0.05 |
| Diluted EPS | $0.11 | $0.15 | $0.04 | $0.05 |
| Weighted Avg Shares Outstanding | $1.45B | $1.44B | $1.44B | $1.44B |
| Weighted Avg Shares Outstanding (Diluted) | $1.45B | $1.44B | $1.44B | $1.44B |
Financial performance has remained strong, with revenue growing from $2.25B in Q2 2024 to $4.32B in Q1 2025. Gross profit continued to perform well, with margins at 38% in the latest quarter. Operating income reached $247.20M in Q1 2025, holding a steady 6% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $463.90M. Net income dropped to $153.70M, keeping EPS at $0.11. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan